Huron Reports Q1 Revenue of $443.7M, Beating Expectations
Reports Q1 revenue $443.7M, consensus $437.1M. "Revenues before reimbursable expenses (RBR) increased 12% in the first quarter of 2026 compared to 2025, driven by growth across the Healthcare, Education, and Commercial segments, including record RBR performance in Healthcare," said Mark Hussey, chief executive officer and president of Huron. "We also continued our trajectory of margin expansion during the quarter, reflecting disciplined execution by our highly talented team. We are encouraged by the strong start to the year and strength of our pipeline and backlog as we affirm our annual RBR and margin guidance. We continue to believe we are well positioned to serve as our clients' trusted advisor as they evolve their business models and organizations to succeed in challenged markets and in an increasingly AI-enabled world. We remain focused on executing against the market tailwinds driving demand for our business and further strengthening our competitive position to best serve our clients and achieve our financial goals."
Trade with 70% Backtested Accuracy
Analyst Views on HURN
About HURN
About the author

- Complete Exit: Ophir Asset Management fully liquidated its position in Huron Consulting Group during Q1 2026, selling 244,302 shares for an estimated $36.73 million, indicating a potential loss of investor confidence in the firm.
- Market Value Decline: The transaction resulted in a $42.24 million decrease in Huron's quarter-end market value, highlighting the direct impact of market price fluctuations on the company's valuation and possibly affecting investor sentiment.
- Performance Metrics: Despite Huron's Q1 revenue rising 12.1% year-over-year to $443.7 million and adjusted EBITDA climbing nearly 22%, the stock has fallen 30%, suggesting concerns about its future growth amidst market volatility.
- Future Outlook: Huron's CEO acknowledged challenges in an AI-driven market, and while the company maintains a full-year revenue guidance of up to $1.86 billion, investors are closely watching its ability to sustain pricing power and margins as automation becomes more prevalent.
- Share Reduction Transaction: Aristotle Capital sold 40,351 shares of Huron Consulting Group in Q1 2026, with an estimated trade value of approximately $6.07 million, indicating a reduction in confidence towards the company.
- Declining Share Value: As of the end of Q1 2026, Aristotle Capital held about 249,912 shares of Huron worth $31.90 million, but the net position value declined by $18.29 million during the period, reflecting weakened market confidence in Huron.
- Performance Metrics: Despite a 30% drop in stock price, Huron's Q1 2026 revenue grew 12% year-over-year to a record $443.7 million, with adjusted EBITDA rising nearly 22%, showcasing strong demand in the healthcare consulting sector.
- Future Outlook: Huron anticipates revenue of up to $1.86 billion in 2026, with healthcare accounting for 51% of total revenue, as management continues to focus on digital transformation and AI-related consulting demand, indicating potential for long-term growth.
- Significant Revenue Growth: Huron's Q1 revenue reached $451.8 million, surpassing analyst expectations of $448.6 million with an 11.8% year-on-year increase, demonstrating strong performance in the healthcare sector and further solidifying its market position.
- Improved Profitability: Adjusted EPS was $1.73, exceeding analyst estimates of $1.60 with an 8% increase, reflecting the company's success in cost control and rising service demand, which enhances investor confidence.
- Strong Orders and Pipeline: Bookings increased over 20% across all segments, with historically high backlog coverage and near-record pipeline levels, indicating sustainability and growth potential for future performance.
- AI Investment Strategy: CEO Hussey emphasized that AI capability development relies primarily on organic investments, complemented by targeted partnerships, showcasing the company's forward-looking approach in technological innovation, which is expected to drive future business growth.
- Complete Exit: Lisanti Capital fully exited its position in Huron Consulting Group by selling 45,590 shares in Q1 2026 for an estimated $6.85 million, indicating a total loss of confidence in the firm's investment thesis.
- Net Position Change: The transaction resulted in a net position change of $7.88 million at quarter-end, reflecting fluctuations in Huron's share price during the period, suggesting market skepticism regarding the company's future prospects.
- Poor Performance: As of May 6, 2026, Huron's shares were priced at $120.11, down 19.5% over the past year, significantly underperforming the S&P 500 by 50.9 percentage points, highlighting its weak market performance.
- Investor Concerns: Despite Huron's Q1 earnings beating expectations with a 12% revenue increase, Lisanti's decision to sell before the results indicates caution regarding the sustainability of future growth, reflecting broader market concerns about consulting demand.
- Significant Revenue Growth: In Q1 2026, Huron Consulting Group's revenues before reimbursable expenses (RBR) increased by 12% year-over-year to $443.7 million, driven by strong performance across healthcare, education, and commercial segments, particularly in healthcare where RBR reached record levels, indicating the company's competitive position in the market.
- Healthcare Segment Outperformance: The healthcare segment saw a 14% increase in RBR with an organic growth rate of 10%, despite challenges such as rising operational costs and labor shortages, demonstrating the company's effective strategies in addressing client needs and market pressures.
- Strong Growth in Commercial Sector: The commercial segment experienced a 22% increase in RBR, with an organic growth rate of 8%, reflecting that the company's investments have yielded more durable growth, showcasing its adaptability and business resilience in a competitive landscape.
- Stable Financial Outlook: The company reaffirmed its 2026 guidance for RBR in the range of $1.78 billion to $1.86 billion and adjusted EBITDA margin of 14.5% to 15%, indicating management's confidence in future performance despite market challenges.
- Earnings Announcement Schedule: Huron will release its financial results for the first quarter ended March 31, 2026, after market close on May 5, 2026, providing investors with the latest performance data.
- Conference Call Details: CEO C. Mark Hussey and CFO John D. Kelly will host a conference call on May 5, 2026, at 5:00 p.m. Eastern Time (4:00 p.m. Central Time) to discuss the financial results, enhancing transparency for stakeholders.
- Webcast Access: The conference call will be webcast by Notified, allowing investors to access it via Huron's website, ensuring broad participation and information dissemination.
- Replay Availability: A replay will be available approximately two hours after the conclusion of the call and will remain accessible for 90 days, providing convenience for investors who could not participate live.










